Qian Ding

532 total citations
19 papers, 398 citations indexed

About

Qian Ding is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Qian Ding has authored 19 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 10 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Qian Ding's work include Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Qian Ding is often cited by papers focused on Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Qian Ding collaborates with scholars based in China, United States and Japan. Qian Ding's co-authors include Chunqing Zhang, Zhen Li, Tarik Möröy, Tiemo J. Klisch, Lin Gan, Jiafang Wang, Matthew Bjerknes, Tomoyuki Fujiyama, Mikio Hoshino and Cyrus Khandanpour and has published in prestigious journals such as Developmental Biology, American Journal Of Pathology and World Journal of Gastroenterology.

In The Last Decade

Qian Ding

19 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qian Ding China 10 156 133 131 75 54 19 398
Nadia Navari Italy 12 156 1.0× 132 1.0× 122 0.9× 69 0.9× 53 1.0× 17 411
Hirosumi Oide Japan 11 139 0.9× 109 0.8× 151 1.2× 101 1.3× 33 0.6× 22 378
Kristina Kannisto Sweden 11 84 0.5× 162 1.2× 116 0.9× 214 2.9× 103 1.9× 14 435
Michelle Melino Australia 11 170 1.1× 84 0.6× 161 1.2× 57 0.8× 18 0.3× 16 393
Marina Nati Germany 7 255 1.6× 110 0.8× 69 0.5× 33 0.4× 26 0.5× 8 417
Yeni Ait Ahmed United States 11 183 1.2× 90 0.7× 145 1.1× 59 0.8× 37 0.7× 14 386
Yuan Zhuang China 10 195 1.3× 108 0.8× 115 0.9× 45 0.6× 30 0.6× 21 365
Arfianti Arfianti Indonesia 6 187 1.2× 108 0.8× 61 0.5× 54 0.7× 26 0.5× 29 359
P Georgiev Switzerland 6 134 0.9× 145 1.1× 158 1.2× 116 1.5× 75 1.4× 7 382
Karin Diggle United States 10 111 0.7× 108 0.8× 65 0.5× 38 0.5× 17 0.3× 12 284

Countries citing papers authored by Qian Ding

Since Specialization
Citations

This map shows the geographic impact of Qian Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Ding more than expected).

Fields of papers citing papers by Qian Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Ding. The network helps show where Qian Ding may publish in the future.

Co-authorship network of co-authors of Qian Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Ding. A scholar is included among the top collaborators of Qian Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Ding. Qian Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ding, Qian, Qian Zhao, Na Li, et al.. (2025). Albumin-bilirubin grade as an alternative to Child–Pugh class for evaluating liver function within staging systems for hepatocellular carcinoma. Discover Oncology. 16(1). 394–394. 1 indexed citations
2.
Ding, Qian, et al.. (2024). The α‐1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis. Advanced Biology. 8(6). e2300513–e2300513. 1 indexed citations
3.
Wang, Jinchao, Guangchuan Wang, Wanli Jiang, et al.. (2023). Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation. International Immunopharmacology. 115. 109605–109605. 9 indexed citations
4.
Wang, Sining, et al.. (2023). Upregulation of ATG9b by propranolol promotes autophagic cell death of hepatic stellate cells to improve liver fibrosis. Journal of Cellular and Molecular Medicine. 28(2). e18047–e18047. 3 indexed citations
5.
Zhang, Shiyu, Qian Ding, Na Li, et al.. (2023). The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(3). 949–949. 39 indexed citations
6.
Chen, Qiuyu, Lingyun Zhang, Xin Xu, et al.. (2023). Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma. International Journal of Oncology. 63(1). 4 indexed citations
7.
Liao, Yusheng, Qiuyu Chen, Mengshi Chen, et al.. (2022). Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021. Clinical and Experimental Medicine. 23(6). 2759–2772. 11 indexed citations
8.
Ding, Qian, Xiangxu Kong, Weilong Zhong, & Wentian Liu. (2022). Fecal biomarkers: Non-invasive diagnosis of colorectal cancer. Frontiers in Oncology. 12. 971930–971930. 14 indexed citations
9.
10.
11.
Ding, Qian, et al.. (2021). Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway. Drug Design Development and Therapy. Volume 15. 3643–3659. 54 indexed citations
12.
Ding, Qian, Xiao‐Li Xie, Miaomiao Wang, et al.. (2019). The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Experimental & Molecular Medicine. 51(1). 1–13. 46 indexed citations
13.
14.
Ding, Qian, et al.. (2018). Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway. Human Pathology. 76. 37–46. 15 indexed citations
15.
Ding, Qian, Lei Chen, Jia Wang, et al.. (2017). Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice. The American Journal of the Medical Sciences. 354(2). 199–210. 8 indexed citations
16.
Wang, Ruisi, Qian Ding, Thiago M. de Assuncao, et al.. (2016). Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate–Induced Cell Migration. American Journal Of Pathology. 187(1). 134–145. 5 indexed citations
17.
Ding, Qian. (2015). Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World Journal of Gastroenterology. 21(32). 9566–9566. 40 indexed citations
18.
Wu, Xiangsong, Maolan Li, Wenguang Wu, et al.. (2013). [The role of preoperative TACE on hepatocellular carcinoma located in caudate lobe].. PubMed. 51(9). 780–3. 1 indexed citations
19.
Bjerknes, Matthew, Cyrus Khandanpour, Tarik Möröy, et al.. (2011). Origin of the brush cell lineage in the mouse intestinal epithelium. Developmental Biology. 362(2). 194–218. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Navari Breakdown of academic impact, for papers by Hirosumi Oide Breakdown of academic impact, for papers by Kristina Kannisto Breakdown of academic impact, for papers by Michelle Melino Breakdown of academic impact, for papers by Marina Nati Breakdown of academic impact, for papers by Yeni Ait Ahmed Breakdown of academic impact, for papers by Yuan Zhuang Breakdown of academic impact, for papers by Arfianti Arfianti Breakdown of academic impact, for papers by P Georgiev Breakdown of academic impact, for papers by Karin Diggle
Rankless by CCL
2026